Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Optimal Dose of IV Oxycodone for Postoperative Pain
NCT02732262Phase 3Completed
- Sponsor
- Seoul National University Hospital
- Start
- Apr 2016
- Primary completion
- Jul 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of oxycodone in postoperative pain (3 arms), sponsored by Seoul National University Hospital. Primary endpoint: Resting postoperative pain at 24hr. Started Apr 2016; status: completed.
02
Drugs
oxycodone
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT02732262.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02732262.